Globus Medical raises 2026 EPS guidance to $4.40-$4.50 with margin gains following record Q4 results

Q4 2025 earnings call recap: revenue/EPS beats, margin expansion, Nevro integration, and raised 2026 guidance—read key takeaways.
Morningstar

Vertiv Reports Strong Fourth Quarter with Organic Orders Growth of 252% and Diluted EPS Growth of 200% (Adjusted Diluted EPS +37%)

Information reconciling certain forward-looking GAAP measures to non-GAAP measures related to FY 2026 guidance, including organic net sales growth, adjusted operating margin and adjusted free cash ...